Tilray | TRLY - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Acasti Pharma USD 459K 881K 2025-09
Akebia Therapeutics USD 9.42M 1.04M 2026-06
Alaunos Therapeutics USD 400K 213K 2026-03
Aurora Cannabis CAD 9.31M 58.72M 2026-03
Avita Medical AUD 8.96M 1.69M 2025-12
Canopy Growth CAD 34.82M 14.85M 2026-03
Cronos Group USD 17.42M 7.14M 2026-06
Dianthus Therapeutics USD 6.39M 1.12M 2026-06
Divis Laboratories Ltd INR 12.11B 1.71B 2026-03
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
IQVIA Holdings USD 3.61B 31M 2026-06
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Moderna USD 167M 6M 2026-06
Organigram Holdings CAD 73.14M 2.06M 2026-03
Organon & Co USD 1.05B 68M 2026-06
Revvity USD 165.74M 3.94M 2026-06
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Viatris USD 1.24B 40.6M 2026-06
Xeris Pharmaceuticals USD 9.34M 2.13M 2026-06
Zealand Pharma A/S 171M 175.6M 2026-03